Skip to main content
. 1999 Jun;127(4):843–852. doi: 10.1038/sj.bjp.0702592

Figure 5.

Figure 5

Quantified data (expressed as percentage of control) for inhibition of the DR-EPSP amplitude and duration by m-ChPB (50 μM) after pre-treatment with bicuculline (30 μM), saclofen (50 μM) or naloxone (50 μM) (**P<0.01; ***P<0.005).